Exploring Serum Biomarkers for Neuropathic Pain in Rat Models of Chemotherapy-Induced Peripheral Neuropathy: A Comparative Pilot Study with Oxaliplatin, Paclitaxel, Bortezomib, and Vincristine.

Autor: Balayssac D; Direction de la Recherche Clinique et de l'Innovation, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France.; INSERM U1107 NEURO-DOL, Université Clermont Auvergne, F-63000 Clermont-Ferrand, France., Durif J; Laboratoire de Biochimie et de Génétique Moléculaire, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France., Lambert C; Unité de Biostatistiques, Direction de la Recherche Clinique et de l'Innovation, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France., Dalbos C; INSERM U1107 NEURO-DOL, Université Clermont Auvergne, F-63000 Clermont-Ferrand, France., Chapuy E; INSERM U1107 NEURO-DOL, Université Clermont Auvergne, F-63000 Clermont-Ferrand, France., Etienne M; Metabolic Adaptations to Exercise under Physiological and Pathological Conditions (AME2P), Université Clermont Auvergne, F-63000 Clermont-Ferrand, France., Demiot C; UR 20218-Neuropathies et Innovations Thérapeutiques (NeurIT), Faculties of Medicine and Pharmacy, University of Limoges, F-87025 Limoges, France., Busserolles J; INSERM U1107 NEURO-DOL, Université Clermont Auvergne, F-63000 Clermont-Ferrand, France., Martin V; Metabolic Adaptations to Exercise under Physiological and Pathological Conditions (AME2P), Université Clermont Auvergne, F-63000 Clermont-Ferrand, France.; Institut Universitaire de France (IUF), F-75000 Paris, France., Sapin V; Laboratoire de Biochimie et de Génétique Moléculaire, CNRS, INSERM, iGReD, CHU Clermont-Ferrand, Université Clermont Auvergne, F-63000 Clermont-Ferrand, France.

Publikováno v: Toxics [Toxics] 2023 Dec 08; Vol. 11 (12). Date of Electronic Publication: 2023 Dec 08.

P16-11 In search of sensitive safety biomarkers of peripheral neurotoxicity in the rat: a collaborative effort across industry and academia (IMI NeuroDeRisk project)

Autor: Di Cesare Mannelli, L., Balayssac, D., Busserolles, J., Dalbos, C., Prival, L., Richard, D., Quintana, M., Micheli, L., Toti, A., Ferrara, V., Ghelardini, C., Vlasakova, K., Glaab, W.E., Hu, Y., Loryan, I., Wursch, K., Dubost, V., Johnson, E., Penrrat, K., Theil, D.

Publikováno v: In Toxicology Letters 1 September 2022 368 Supplement:S222-S222

Analgesic and preventive effects of donepezil in animal models of chemotherapy-induced peripheral neuropathy: Involvement of spinal muscarinic acetylcholine M2 receptors.

Autor: Selvy M; Université Clermont Auvergne, CHU Clermont-Ferrand, Service de Chirurgie et d'oncologie digestive, INSERM U1107 NEURO-DOL, Clermont-Ferrand F-63000, France. Electronic address: marieselvy@hotmail.fr., Mattévi C; Université Clermont Auvergne, CHU Clermont-Ferrand, Service de Chirurgie et d'oncologie digestive, INSERM U1107 NEURO-DOL, Clermont-Ferrand F-63000, France. Electronic address: catherine.mattevi@gmail.com., Dalbos C; Université Clermont Auvergne, INSERM U1107 NEURO-DOL, Clermont-Ferrand F-63000, France. Electronic address: cristelle.dalbos@uca.fr., Aissouni Y; Université Clermont Auvergne, INSERM U1107 NEURO-DOL, Clermont-Ferrand F-63000, France. Electronic address: youssef.aissouni@inserm.fr., Chapuy E; Université Clermont Auvergne, INSERM U1107 NEURO-DOL, Clermont-Ferrand F-63000, France. Electronic address: eric.chapuy@uca.fr., Martin PY; Université Clermont Auvergne, INSERM U1107 NEURO-DOL, Clermont-Ferrand F-63000, France. Electronic address: martin.pierre.y@gmail.com., Collin A; Université Clermont Auvergne, INSERM U1107 NEURO-DOL, Clermont-Ferrand F-63000, France. Electronic address: aurore.collin@uca.fr., Richard D; CHU Clermont-Ferrand, Laboratoire de Pharmacologie et de Toxicologie, Clermont-Ferrand F-63000, France. Electronic address: drichard@chu-clermontferrand.fr., Dumontet C; Cancer Research Center of Lyon (CRCL), Inserm 1052/CNRS, Université de Lyon, France - Hospices Civils de Lyon, Lyon 69000, France. Electronic address: charles.dumontet@chu-lyon.fr., Busserolles J; Université Clermont Auvergne, INSERM U1107 NEURO-DOL, Clermont-Ferrand F-63000, France. Electronic address: jerome.busserolles@uca.fr., Condé S; Université Clermont Auvergne, CHU Clermont-Ferrand, Service de Neurologie, INSERM U1107 NEURO-DOL, Clermont-Ferrand F-63000, France. Electronic address: sconde@chu-clermontferrand.fr., Balayssac D; Université Clermont Auvergne, CHU Clermont-Ferrand, Délégation à la Recherche Clinique et à l'Innovation, INSERM U1107 NEURO-DOL, Clermont-Ferrand F-63000, France. Electronic address: dbalayssac@chu-clermontferrand.fr.

Publikováno v: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2022 May; Vol. 149, pp. 112915. Date of Electronic Publication: 2022 Apr 06.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Chemotherapy-Induced Peripheral Neuropathy and New Therapeutic Targets: Preclinical Data of Drug Repositioning.

Autor: Balayssac, D.¹, Selvy, M.², Kerckhove, N.¹, Giraudet, F.³, Collin, A.³, Lolignier, S.³, Wersinger, E.³, Busserolles, J.³ jerome.busserolles@uca.fr

Publikováno v: Douleur et Analgésie. sep2022, Vol. 35 Issue 3, p137-143. 7p.